Health
1 read
Viatris Inc. Issues Nationwide Recall of Extended-Release Xanax Tablets

Want the full story?
Read the complete article at KTSM
AI Summary
Viatris Inc. has announced a voluntary recall of a particular lot of extended-release Xanax (alprazolam) tablets due to safety concerns. This recall is significant as it affects consumers who rely on this medication for anxiety management. The recall underscores the importance of monitoring pharmaceuticals for quality and safety. Patients using this medication should check their prescriptions against the recalled lot and consult with healthcare providers if they have any concerns.
health recall pharmaceuticals xanax viatris
People & Organizations
Viatris Inc.